Skip to content

LIPO

Lipella Pharmaceuticals Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.00
+0.00%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-99.4%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
May 15, 2024Kaufman Jonathan H · director, 10 percent owner, officer: See remarks below.Purchase10,000$0.76
Mar 19, 2024Pruchnic Ryan · directorA-Award25,000$0.77
Mar 19, 2024Yoshimura Naoki · directorA-Award25,000$0.77
Mar 19, 2024Chancellor Michael B · director, 10 percent owner, officer: Chief Medical OfficerA-Award80,000$0.77
Mar 19, 2024Birder Lori · directorA-Award25,000$0.77
Mar 19, 2024Kaufman Jonathan H · director, 10 percent owner, officer: See remarks below.Purchase25,000$0.87
Mar 19, 2024Kaufman Jonathan H · director, 10 percent owner, officer: See remarks below.Purchase30,000$0.79
Mar 19, 2024Kaufman Jonathan H · director, 10 percent owner, officer: See remarks below.A-Award80,000$0.77
Mar 19, 2024Johnston Douglas · officer: Chief Financial OfficerA-Award50,000$0.77
Mar 19, 2024Cohen Daniel R · directorA-Award25,000$0.77
Mar 19, 2024Kim Byong · directorA-Award25,000$0.77
Mar 15, 2024Kaufman Jonathan H · director, 10 percent owner, officer: See remarks below.A-Award144,906$0.69
Mar 15, 2024Chancellor Michael B · director, 10 percent owner, officer: Chief Medical OfficerA-Award144,906$0.69
Jun 21, 2023Cohen Daniel R · directorA-Award25,000$2.19
Jun 21, 2023Battleman David S. · directorA-Award25,000$2.19
Jun 21, 2023Pruchnic Ryan · directorA-Award25,000$2.19
Jun 21, 2023Kaufman Jonathan H · director, 10 percent owner, officer: See remarks below.A-Award79,500$2.19
Jun 21, 2023Chancellor Michael B · director, 10 percent owner, officer: Chief Medical OfficerA-Award79,500$2.19
Jun 21, 2023Yoshimura Naoki · directorA-Award25,000$2.19
Jun 21, 2023Kim Byong · directorA-Award25,000$2.19
Jun 21, 2023Johnston Douglas · officer: Chief Financial OfficerA-Award50,000$2.19

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing May 15, 2024